A comprehensive synthesis of the immunotherapeutic paradigm in BC is offered, spanning ICIs, adoptive cellular therapies (CAR-T, CAR-NK, CAR-NK, CAR-M, TIL, TCR-T, and CIK cells), and emerging immune modulators.
Ali Mussa, Mahasin Hamid, M. Talib et al.· Journal of Translational Med...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.